Latest Breaking News On - Prnewswire icecure medical ltd - Page 6 : comparemela.com

IceCure Medical Ltd Announces Proposed Public Offering

/PRNewswire/ IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the.

New yorkUnited statesRonen tsimermanSecurities exchange commissionPrnewswire icecure medical ltdArcadia securitiesDrug administrationCompany annual report on formExchange commissionA gp alliance global partnersIcecure medical ltdCure medicalAlliance global partnersCapital marketsPrivate securities litigation reform actRisk factors

IceCure s ProSense Safe and Effective in Treating Kidney Tumors with 89 5% Recurrence-Free Rate Based on Interim Study Results

/PRNewswire/ - IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the.

United statesRonen tsimermanHalahmi sarelEyal shamirSecurities exchange commissionPrnewswire icecure medical ltdDrug administrationWorld cancer research fund internationalCompany annual report on formShamir medical centerUrological association conference in eilatNasir said of bnai zion medical centerIcecure medical ltdAmerican cancer societyUrological association conferenceCure medical

IceCure Medical Reports Financial Results for the Nine Months Ended September 30, 2022 and Provides Update on Recent Operational Highlights

IceCure Medical Reports Financial Results for the Nine Months Ended September 30, 2022 and Provides Update on Recent Operational Highlights
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Republic ofUnited statesRonen tsimermanemailEyal shamirHania bednarskiProsense cryoprobesCenters for medicare medicaid servicesIsrael internationalPrnewswire icecure medical ltdVietnam ministry of healthDrug administrationCompany annual report on formDepartment of medical equipmentBrazilian health regulatory agencyTerumo corporationIcecure medical ltd

TIME CHANGE: IceCure Medical to Report Financial Results for the 9-Month Period Ended September 30, 2022 and Conduct Conference Call on December 5, 2022

/PRNewswire/ IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the.

Icecure prosenseHania bednarskiCompany annual report on formIsrael internationalPrnewswire icecure medical ltdDrug administrationCure medicalSerenity surgeryBreast cancerProsense systemPrivate securities litigation reform actRisk factorsAnnual reportIcecure medical

IceCure Medical to Report Financial Results for the 9-Month Period Ended September 30, 2022 and Conduct Conference Call on December 5, 2022

/PRNewswire/ IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the.

Icecure prosenseRonen tsimermanHania bednarskiCompany annual report on formIsrael internationalPrnewswire icecure medical ltdDrug administrationCure medicalSerenity surgeryBreast cancerProsense systemPrivate securities litigation reform actRisk factorsAnnual reportIcecure medicalArtificial intelligence